28 KRW
12.87 B KRW
28.01 B KRW
76.34 M
About ORIENTBIO
Sector
CEO
Jae-Jin Jang
Website
Headquarters
Seongnam-si
Founded
1959
ISIN
KR7002630002
FIGI
BBG000BDR5X1
ORIENTBIO, Inc. engages in the research and development of biotechnology. It manufactures and sells biological materials and bio experiment apparatus. It also provides research models such as rabbits and mice, contract research organization services, and solutions for biomedical research. The company was founded on April 16, 1959 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 002630 is 1,547 KRW — it has increased by 30.00% in the past 24 hours. Watch ORIENTBIO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ORIENTBIO stocks are traded under the ticker 002630.
002630 stock has risen by 13.83% compared to the previous week, the month change is a 222.29% rise, over the last year ORIENTBIO has showed a 156.13% increase.
002630 reached its all-time high on Aug 4, 2005 with the price of 10,510 KRW, and its all-time low was 401 KRW and was reached on Mar 19, 2020. View more price dynamics on 002630 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002630 stock is 29.48% volatile and has beta coefficient of 1.65. Track ORIENTBIO stock price on the chart and check out the list of the most volatile stocks — is ORIENTBIO there?
Today ORIENTBIO has the market capitalization of 141.10 B, it has increased by 8.30% over the last week.
Yes, you can track ORIENTBIO financials in yearly and quarterly reports right on TradingView.
002630 net income for the last quarter is −1.09 B KRW, while the quarter before that showed −6.78 B KRW of net income which accounts for 83.91% change. Track more ORIENTBIO financial stats to get the full picture.
No, 002630 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 106.00 employees. See our rating of the largest employees — is ORIENTBIO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORIENTBIO EBITDA is 6.33 B KRW, and current EBITDA margin is 25.49%. See more stats in ORIENTBIO financial statements.
Like other stocks, 002630 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORIENTBIO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORIENTBIO technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORIENTBIO stock shows the buy signal. See more of ORIENTBIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.